GD
Therapeutic Areas
Indapta Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| G-NK cells + mAb | Relapsed/Refractory Non-Hodgkin's Lymphoma and Multiple Myeloma | Phase 1 |
| G-NK cells | Multiple Sclerosis | Phase 1 |
| Drug | Indication | Phase |
|---|---|---|
| G-NK cells + mAb | Relapsed/Refractory Non-Hodgkin's Lymphoma and Multiple Myeloma | Phase 1 |
| G-NK cells | Multiple Sclerosis | Phase 1 |